Protocol Deviations Prompt 483s for Clinical Investigators By Sam | July 6, 2016 Three clinical investigators were cited for deviating from their investigational plans recently by the FDA for a litany of different reasons. Source: Drug Industry Daily Posted in Drug Industry Daily